Prot#CP1005B017: A Phase II, Multi-center, Open-label Study Evaluating the Efficacy and Safety of GRN1005 in Non-Small Cell Lung Cancer Patients with Brain Metastases

  • Raizer, Jeffrey J (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/29/123/1/15

Funding

  • Clinical Financial Services, LLC (CP1005B017)
  • Geron Corporation (CP1005B017)